Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16220 | TPP | 1/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 10:39:16 UTC | View, Job request 16220 |
| Succeeded | OpenSAFELY Internal | opensafely-internal-interactive | 16219 | TPP | 9/9 | Lucy Bridges | 3 years, 1 month ago 10 March 2023 10:21:43 UTC | View, Job request 16219 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16218 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 10:20:13 UTC | View, Job request 16218 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16217 | TPP | 0/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 10:17:35 UTC | View, Job request 16217 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16216 | TPP | 0/1 | Bang Zheng | 3 years, 1 month ago 10 March 2023 09:19:31 UTC | View, Job request 16216 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16215 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 09:18:25 UTC | View, Job request 16215 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16214 | TPP | 1/1 | Bang Zheng | 3 years, 1 month ago 10 March 2023 09:11:05 UTC | View, Job request 16214 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16213 | TPP | 0/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 09:07:12 UTC | View, Job request 16213 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16212 | TPP | 1/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 08:37:52 UTC | View, Job request 16212 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16211 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 08:23:07 UTC | View, Job request 16211 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16210 | TPP | 1/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 07:52:11 UTC | View, Job request 16210 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 16209 | TPP | 2/2 | Bang Zheng | 3 years, 1 month ago 10 March 2023 07:27:18 UTC | View, Job request 16209 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16208 | TPP | 18/18 | Linda Nab | 3 years, 2 months ago 09 March 2023 19:31:53 UTC | View, Job request 16208 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16207 | TPP | 12/12 | Linda Nab | 3 years, 2 months ago 09 March 2023 19:08:32 UTC | View, Job request 16207 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16205 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 18:39:50 UTC | View, Job request 16205 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16204 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 18:32:30 UTC | View, Job request 16204 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16203 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 17:50:01 UTC | View, Job request 16203 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16202 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 17:08:28 UTC | View, Job request 16202 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16197 | TPP | 66/66 | Linda Nab | 3 years, 2 months ago 09 March 2023 16:19:48 UTC | View, Job request 16197 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16194 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:56:06 UTC | View, Job request 16194 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16193 | TPP | 12/12 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:54:36 UTC | View, Job request 16193 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16192 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:42:06 UTC | View, Job request 16192 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16191 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:24:24 UTC | View, Job request 16191 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16189 | TPP | 6/6 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:23:38 UTC | View, Job request 16189 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mabsavs-usernonuser-ccw | 16187 | TPP | 20/20 | Linda Nab | 3 years, 2 months ago 09 March 2023 15:19:54 UTC | View, Job request 16187 |